Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives Average Rating of "Hold" from Analysts

Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) have been given an average recommendation of "Hold" by the eight research firms that are presently covering the firm, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $21.67.

A number of brokerages have recently issued reports on CCRN. TheStreet downgraded shares of Cross Country Healthcare from a "b-" rating to a "c+" rating in a research report on Friday, March 1st. Truist Financial dropped their target price on shares of Cross Country Healthcare from $22.00 to $16.00 and set a "hold" rating on the stock in a research report on Thursday, February 22nd. Benchmark dropped their target price on shares of Cross Country Healthcare from $24.00 to $21.00 and set a "buy" rating on the stock in a research report on Thursday, February 22nd. Finally, Barrington Research dropped their target price on shares of Cross Country Healthcare from $26.00 to $24.00 and set an "outperform" rating on the stock in a research report on Tuesday, February 27th.

Read Our Latest Report on Cross Country Healthcare

Insider Buying and Selling at Cross Country Healthcare

In other Cross Country Healthcare news, insider Karen Mote sold 6,216 shares of Cross Country Healthcare stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $16.95, for a total transaction of $105,361.20. Following the completion of the sale, the insider now directly owns 35,101 shares in the company, valued at approximately $594,961.95. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 5.50% of the company's stock.


Hedge Funds Weigh In On Cross Country Healthcare

Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Cross Country Healthcare by 1.8% in the 4th quarter. Vanguard Group Inc. now owns 2,505,906 shares of the business services provider's stock valued at $56,734,000 after purchasing an additional 44,421 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Cross Country Healthcare by 14.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,189 shares of the business services provider's stock valued at $344,000 after purchasing an additional 1,970 shares during the period. Barclays PLC lifted its stake in shares of Cross Country Healthcare by 81.2% in the 4th quarter. Barclays PLC now owns 78,389 shares of the business services provider's stock valued at $1,775,000 after purchasing an additional 35,126 shares during the period. Public Sector Pension Investment Board lifted its stake in shares of Cross Country Healthcare by 64.8% in the 4th quarter. Public Sector Pension Investment Board now owns 68,571 shares of the business services provider's stock valued at $1,552,000 after purchasing an additional 26,974 shares during the period. Finally, Bridgeway Capital Management LLC lifted its stake in shares of Cross Country Healthcare by 2.0% in the 4th quarter. Bridgeway Capital Management LLC now owns 481,531 shares of the business services provider's stock valued at $10,902,000 after purchasing an additional 9,408 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Cross Country Healthcare Price Performance

Shares of Cross Country Healthcare stock traded up $0.06 during trading on Friday, hitting $17.56. The stock had a trading volume of 186,896 shares, compared to its average volume of 473,924. The firm's fifty day simple moving average is $18.45 and its 200-day simple moving average is $20.76. The stock has a market cap of $608.98 million, a PE ratio of 8.65, a PEG ratio of 1.87 and a beta of 0.75. Cross Country Healthcare has a 12 month low of $15.65 and a 12 month high of $28.75.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its earnings results on Wednesday, February 21st. The business services provider reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.02. The firm had revenue of $414.04 million during the quarter, compared to analyst estimates of $404.42 million. Cross Country Healthcare had a net margin of 3.60% and a return on equity of 16.93%. The business's revenue was down 34.1% on a year-over-year basis. During the same quarter last year, the business earned $1.09 EPS. Analysts expect that Cross Country Healthcare will post 0.94 earnings per share for the current fiscal year.

About Cross Country Healthcare

(Get Free Report

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Stories

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

→ FW: 234x Gain (From Weiss Ratings) (Ad)

Should you invest $1,000 in Cross Country Healthcare right now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: